dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2020-12-10T19:48:20Z
dc.date.accessioned2022-12-19T20:18:12Z
dc.date.available2020-12-10T19:48:20Z
dc.date.available2022-12-19T20:18:12Z
dc.date.created2020-12-10T19:48:20Z
dc.date.issued2020-01-01
dc.identifierRevista Da Sociedade Brasileira De Medicina Tropical. Brasilia: Soc Brasileira Medicina Tropical, v. 53, 4 p., 2020.
dc.identifier0037-8682
dc.identifierhttp://hdl.handle.net/11449/196543
dc.identifier10.1590/0037-8682-0210-2019
dc.identifierS0037-86822020000100623
dc.identifierWOS:000510394200001
dc.identifierS0037-86822020000100623.pdf
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5377180
dc.description.abstractIntroduction: Hepatitis C virus (HCV) infection is involved in the pathogenesis of autoimmune and rheumatic disorders. Although the human platelet antigens (HPA) polymorphism are associated with HCV persistence, they have not been investigated in rheumatological manifestations (RM). This study focused on verifying associations between allele and genotype HPA and RM in patients with chronic hepatitis C. Methods: Patients (159) with chronic hepatitis C of both genders were analyzed. Results: Women showed association between HPA-3 polymorphisms and RM. Conclusions: An unprecedented strong association between rheumatological manifestations and HPA-3 polymorphism, possibly predisposing women to complications during the disease course, was observed.
dc.languageeng
dc.publisherSoc Brasileira Medicina Tropical
dc.relationRevista Da Sociedade Brasileira De Medicina Tropical
dc.rightsAcesso aberto
dc.sourceWeb of Science
dc.subjectHepatitis C
dc.subjectHuman platelet antigens
dc.subjectPolymorphism
dc.subjectRheumatological manifestations
dc.titleHuman platelet antigen-3 polymorphism as a risk factor for rheumatological manifestations in hepatitis C
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución